During the fellowship, Dr. Eliaz gave his recommendations on holistic and integrative approaches to treating cancer. “I was thrilled to meet a group of enthusiastic physicians and health providers who are interested in and committed to learning and practicing integrative oncology,” said Eliaz. “It is my belief and experience that integrating the best medical practices -- from both East and West -- with an open heart guided by love, compassion, and empowerment of the patient can offer true transformation in healthcare.”
Dr. Eliaz says a large focus of his practice incorporates the most important scientific breakthroughs in integrative and complementary medicine. “There is now a significant body of research validating many ancient as well as modern approaches to treating illness using botanical-based medicine. As an Integrative Cancer Physician, a central focus of my practice is to bring together top well-researched treatments from both conventional and natural medicine in order to design each patient’s protocol with an emphasis on the person as a whole.”
Groundbreaking New Research on the Role of Galectin-3 Molecules
Inspired by cutting-edge research on natural health solutions, Dr. Eliaz presented new evidence on the positive effects of Modified Citrus Pectin (derived from the pith of citrus fruit peels) in blocking unhealthy levels of galectin-3 molecules in the body. Dr. Eliaz says, “galectin-
These new discoveries give Modified Citrus Pectin even greater potential in the prevention and treatment of many serious health conditions for which there are currently limited or no treatments available.
Testing For Elevated Galactin-3 Levels
Early detection of any disease is critical for prevention and recovery. A new blood test that measures circulating levels of galectin-3 has been approved by the FDA and most types of health insurance as a useful tool in helping to determine cardiovascular disease risk and prognosis. This test can also be used to determine risks of cancer metastasis. The development and use of this simple blood test by conventional medicine means that galectin-3 is now on its way to being widely accepted and used as a therapeutic target in conditions from congestive heart failure to metastatic cancer, among others.
“As more research continues on the role of galectin-3 in a wide range of diseases, the usefulness of Modified Citrus Pectin will continue to grow as well, offering new hope to patients seeking safe and effective therapies for fighting disease and restoring health naturally,” says Dr. Eliaz.
About Dr. Isaac Eliaz
Dr. Isaac Eliaz, M.D., MS., L.Ac. has been a pioneer in integrative medicine since the early 1980s. He is a respected researcher, innovative product formulator, clinical practitioner, author and lecturer. Dr. Eliaz is widely regarded as the leading expert in the field of Modified Citrus Pectin research and has been using Modified Citrus Pectin in his clinical practice for over 15 years to treat a variety of conditions. For more about Dr. Isaac Eliaz’s health recommendations and research, visit DrEliaz.org or call (707) 583-8622 to schedule a personal interview.
# # #
About Better Health Publishing:
Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.